Pre‑eclampsia from the perspective of inter- professional collaboration

Česká verze

Authors: Petr Janků ; K. Janků; V. Unzeitig
Authors place of work: Gynekologicko‑porodnická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MU Dr. Pavel Ventruba, DrSc.
Published in the journal: Vnitř Lék 2009; 55(12): 1159-1166
Category: Přehledné referáty

Summary

Preeclampsia- eclampsia is a syndrome which covers the area of influence belonging to gynecologists- obstetricians. However the internists, especially those who work as consultants in obstetric departments, are interested in diagnostics and therapy of this problem as well. Though internists working in the outdoor- departments do not face the problems of preeclampsia so often, it will be usefull to inform them about the latest trends in diagnostics and therapy of this syndrome, which may be very risky in pregnancy. The physicians in general (except the gynecologists) consider preeclampsia mostely as one form of hypertension that appears sometimes during gravidity and they do not realy appreciate the complex danger of this illness for the both, mother and child. The objective of this paper is to inform the general medical public, especially the internists and general practitioners about the modern view of the main problems of preeclampsia e. g. the pathogenesis, diagnostics and the up to day therapy of this high risky syndrome joined with pregnancy.

Key words:
preeclampsia- eclampsia – pathogenesis – diagnostics – complications – therapy – hypertension in pregnancy – HELLP syndrome

Zdroje

1. Sibai B, Dekker G, Kupferminc M. Pre‑eclampsia. Lancet 2005; 365: 785– 799.

2. Kus E, Kazimierak W, Brzozowska M et al. Arterial hypertension in pregnant women. Przegl Lek 2004; 61: 968– 971.

3. Depypere HT, Langlois MR, Delanghe JR et al. Haptoglobin polymorphism in patients with preeclampsia. Clin Chem Lab Med 2006; 44: 924– 928.

4. Luppi P, Tse H, Lain KY et al. Preeclampsia activates circulating immune cells with engagement of the NF‑ kappaB pathway. Am J Reprod Immunol 2006; 56: 135– 144.

5. Malberg H, Bauernschmitt R, Voss A et al. Analysis of cardiovascular oscillations: a new approach to the early prediction of pre‑eclampsia. Chaos 2007; 17: 015113.

6. de Carvalho MR, Campos Hde H, Bruno ZV et al. Predictive factors for pregnancy hypertension in primiparous adolescents: analysis of prenatal care. ABPM and microalbuminuria. Arq Bras Cardiol 2006; 87: 487– 495.

7. Guilleminault C, Palombini L, Poyares D et al. Preeclampsia and nasal CPAP. Part 1. Early intervention with nasal CPAP in pregnant women with risk‑factors for preeclampsia: Preliminary findings. Sleep Med 2007; 9: 9– 14.

8. Qiu C, Phung TT, Vadachkoria S et al. Oxidized low‑ density lipoproteid (oxidized LDL) and the risk of preeclampsia. Physiol Res 2006; 55: 491– 500.

9. Delmis J. Hypertension in pregnancy. Lijec Vjesn 2006; 128: 357– 368.

10. Tan KH, Kwek K, Yeho GS. Epidemiology of pre‑eclampsia and eclampsia at the KK Women’s and Children’s Hospital, Singapore. Singapore Med J 2006; 47: 48– 53.

11. Doporučení České společnosti pro hypertenzi: Doporučení diagnostických a léčebných postupů u arteriální hypertenze – verze 2007. Hypertenze 2008; XI: 9– 26.

12. Gangaram R, Ojwang PJ, Moodley Jet al. The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy. Hypertens Pregnancy 2005; 24: 117– 123.

13. Cífková R. Hypertenze v těhotenství. Vnitř Lék 2006; 52: 263– 270.

14. Janků P. Diagnostický význam obezity u hypertenze v těhotenství. Scr Med 1993; 66: 96– 97.

15. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991; 266: 237– 241.

16. Hudita D, Russu M, Raluca H. Clinical study of hypertensive disorders in diabetic pregnancy. 28. mezinárodní kongres o patofyziologii v těhotenství. Timisoara. Sborník kongresu 1996: 20– 25.

17. Onofriescu M, Mihaila C, Mocanasu C et al. Hypertension in diabetic pregnancy. 28. mezinárodní kongres o patofyziologii v těhotenství. Timisoara. Sborník kongresu 1996: 505– 510.

18. Janků K, Bělobrádková J, Podroužková B et al. Gestační diabetes mellitus a porucha tolerance glukózy u těhotných trpících esenciální hypertenzí. Diabetologické dny Luhačovice. 22.– 25. 4. 1992. Abstrakta: 18.

19. Tanaka M, Jaamaa G, Kaiser M et al. Racial disparity in hypertensive disorders of pregnancy in New York State: a 10 year longitudinal population based study. Am J Public Health 2007; 97: 163– 170.

20. Janků P. Hypertenze v těhotenství. Interní Med 2007; 9: 91– 95.

21. Janků K. Hypertenze v těhotenství. Brno: IDVPZ 1998.

22. Janků P. Hypertenze a preeklampsie – postupy lege artis. Mod Gyn Porod 2004; 13 (Suppl C): 46– 51.

23. Janků P. Jak postupovat při eklamptickém záchvatu a jeho komplikacích. Gynekologie po promoci 2006; 6: 37– 38.

24. Cífková R. Hypertenze v těhotenství. Kardioforum 2004; 3: 39– 43.

25. Měchurová A. Preeklampsie. Habilitační práce z oboru gynekologie a porodnictví. LF PU v Olomouci 2005.

26. Souček M, Řiháček I, Fráňa P. Léčba hypertenze za speciálních okolností. Med Pro Praxi 2005; 1: 6– 9.

27. Joint National Committee. The 7th report on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003; 42: 1206.

28. Ghulmiyyah LM, Sibai BM. Gestational hypertension – preeclampsia and eclampsia. In: Queenan JT et al (eds). Management of high‑risk pregnancy. 5th ed. Malden: Massachusetts 2007: 271– 279.

29. Měchurová A. Terapie hypertenze. Mod Gyn Porod 2004; 13: 231– 238.

30. Cífková R. Hypertenze v těhotenství. Kap Kardiol 2006; 7: 122– 128.

31. James AH, Bushnell CD, Jamison MG et al. Incidence and risk factors for stroke in pregnancy and puerperium. Obstet Gynecol 2005; 106: 509– 516.

32. Geirsson RT, Arngrimsson R, Apalset E et al. Falling population incidence of eclampsia. A case control study of short term outcome. Acta Obstet Gynecol Scand 1994; 73: 456– 467.

33. Vedra B. Hypertenzní a renální choroby v těhotenství. Praha: Avicenum 1982.

34. Lipka R. HELLP syndroma. Gynekolog 2006; 15: 60– 65.

35. Penka M, Binder T, Unzeitig V et al. Návrh antitrombotické profylaxe a péče o trombofilní stavy v gynekologii a porodnictví. In: Doporučené postupy v perinatologii. Česká Gynek 2009; 74 (Suppl 1): 28– 31.

36. Wagner SJ, Barac S, Garovic VD. Hypertensive pregnancy disorders: current concepts. J Clin Hypertens (Greenwich) 2007; 9: 560– 566.

37. von Dadelszen P, Menzies J, Magee LA. The complications of hypertension in pregnancy. Minerva Med 2005; 96: 287– 302.

38. Janků P. Je těhotenství zátěžovým testem? Gynekologie po promoci 2008; 8: 11– 12.

39. Mignini LE, Villar J, Khan KS. Mapping the theories of preeclampsia: the need for systematic reviews of mechanisms of the disease. Am J Obstet Gynecol 2006; 194: 317– 321.

40. Janku P, Hruban L, Doubek M et al. Importance of some lymphocyte subpopulations and markers of thrombocyte activation in preeclampsia and gestational hypertension. J Matern Fetal Neonatal Med 2008; 21 (Suppl 1): 271.

41. ÚZIS. Rodička a novorozenec 2006. www.uzis.cz.

42. Baldwin KJ, Leighton NA, Kilby MD et al. The West Midlands „Severe hypertensive illness in pregnancy“ (SHIP) audit. Hypertens Pregnancy 2001; 20: 257– 268.

43. Belfort MA, Anthony J, Saade GR et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348: 304– 311.

44. Dukát A, Korbeľ M, Sirotiaková J et al. Hypertenzia a gravidita. Interní Med 2003; 5: 548– 551.

45. Ho JT, Lewis JG, O’Loughlin P et al. Reduced Maternal corticoid‑binding globulin and cortisol levels in pre‑eclampsia and gamate recipient pregnancies. Clin Endocrinol 2007; 66: 869– 877.